The A-share CRO concept sector continued to strengthen during the session, with Innovent rising more than 11%, Minova hitting the daily limit, Biocytogen and Joinn Laboratories both rising more than 7%, and Pris, Chengdu Pioneer, Aorite, Medicilon and others following suit.